Cross-Reactive Bactericidal Antimeningococcal Antibodies Can Be Isolated From Convalescing Invasive Meningococcal Disease Patients Using Reverse Vaccinology 2.0

Frontiers in Immunology - Switzerland
doi 10.3389/fimmu.2018.01621
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA


Related search